ASCO GU 2018: Review of First Presentation: SPARTAN and PROSPER

ASCO GU 2018: Review of First Presentation: SPARTAN and PROSPER  UroToday Earlier Prostate Cancer Drug Use in CRPC Cuts Metastasis Risk  Renal and Urology News SPARTAN Trial Demonstrates Significant Delay of Metastasis With Apalutamide in CRPC  Targeted OncologyFull coverage

Read More ...
ASCO GU 2018: Review of First Presentation: SPARTAN and PROSPER published February 09, 2018 at 10:47AM. Original Source Link : https://www.urotoday.com/conference-highlights/asco-gu-2018/asco-gu-2018-prostate-cancer/101783-asco-gu-2018-review-of-first-presentation-spartan-and-prosper.html

loading...